The foundation invested in Intarcia to help prevent the spread of HIV in Sub-Saharan Africa and other areas where the HIV epidemic is most severe. With help from the foundatin’s investment, Intarcia will work to apply its drug delivery system to create a long-lasting HIV prophylactic implant.
Investment Date: December 2016